Strongbridge Bio Ord (SBBP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.00 +0.03 (+1.52%) 10/05/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.00 unch (unch) -
for Tue, Oct 5th, 2021
Results
download Want to compare other data? Select Fields| Symbol | SBBP | GLSI | SLS | ||
| Company | Strongbridge Bio Ord | Greenwich Lifesciences Inc | Sellas Life Sciences Group Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.96 | 10.15 | 1.4400 | ||
| High | 2.06 | 10.28 | 1.5500 | ||
| Low | 1.95 | 9.94 | 1.3818 | ||
| Last | 2.00 | 10.10 | 1.5500 | ||
| Change | +0.03 | -0.26 | +0.1200 | ||
| % Change | +1.52% | -2.51% | +8.39% | ||
| Volume | 684,600 | 26,200 | 1,783,600 | ||
| 20-Day Average Volume | 234,660 | 159,665 | 1,526,060 | ||
| Previous Close | 1.97 | 10.36 | 1.4300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.10 | 9.52 | 1.2355 | ||
| 20-Day Raw Stochastic | 13.51% | 71.58% | 98.36% | ||
| 20-Day Relative Strength | 42.28% | 48.30% | 72.43% | ||
| Weighted Alpha | -28.48 | -34.68 | -2.42 | ||
| Today's Opinion | 100% Sell | 88% Sell | 88% Buy | ||
| Previous Opinion | 100% Sell | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 88% Sell | 100% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.91% since 09/28/21 | +2.54% since 04/23/25 | +18.32% since 04/23/25 | ||
| Low | 1.95 on 10/05/21 | 9.64 on 04/25/25 | 1.2900 on 04/24/25 | ||
| High | 2.11 on 09/29/21 | 10.86 on 04/24/25 | 1.5600 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | -10.71% since 09/03/21 | -1.17% since 03/28/25 | +39.64% since 03/28/25 | ||
| Low | 1.95 on 10/05/21 | 8.06 on 04/07/25 | 0.9500 on 04/07/25 | ||
| High | 2.32 on 09/10/21 | 10.91 on 04/02/25 | 1.5600 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | -35.06% since 07/02/21 | -23.43% since 01/30/25 | +16.54% since 01/30/25 | ||
| Low | 1.85 on 08/16/21 | 8.06 on 04/07/25 | 0.9500 on 04/07/25 | ||
| High | 3.19 on 07/06/21 | 13.60 on 01/31/25 | 1.8400 on 02/03/25 | ||
| 6-Month | |||||
| %Chg | -28.06% since 04/05/21 | -29.81% since 10/30/24 | +30.25% since 10/30/24 | ||
| Low | 1.85 on 08/16/21 | 8.06 on 04/07/25 | 0.7720 on 12/13/24 | ||
| High | 3.19 on 07/06/21 | 15.47 on 12/02/24 | 1.8400 on 02/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 135,658 | 137,519 | 135,204 | ||
| Shares Outstanding, K | 67,829 | 13,274 | 94,548 | ||
| Annual Sales | 30,730,000 | 0 | 0 | ||
| Annual Net Income | -45,080,000 | -15,790,000 | -30,880,000 | ||
| Last Quarter Sales | 10,040,000 | 0 | 0 | ||
| Last Quarter Net Income | -13,240,000 | -8,040,000 | -6,740,000 | ||
| 60-Month Beta | 1.59 | 1.76 | 2.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/05/21 | -0.61 on 04/15/25 | -0.08 on 03/20/25 | ||
| Latest Earnings Date | 11/04/21 | 05/19/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||